NEU 2.60% $19.31 neuren pharmaceuticals limited

So with a predicted revenue for CY24 for Daybue being...

  1. 5,791 Posts.
    lightbulb Created with Sketch. 735

    So with a predicted revenue for CY24 for Daybue being $370m-$420m and the first quarter predicted at $80m it would seem that these figures may indicate quarterly growth of 10-15% with $95m, $115m and $130m taking figures up to $420m


    If we use the lower end of growth at 10% for year 2025 we would get

    Q1 $100m

    Q2 $140m

    Q3 $155m

    Q4 $170m

    or totalling ~ $550m and the trigger of another $50m milestone payment

    Also 2025 should see some revenue flow from Canada


    Not bad year on year revenue where it would seem various milestone triggers will complement royalties for a few years to come


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.31
Change
0.490(2.60%)
Mkt cap ! $2.465B
Open High Low Value Volume
$19.14 $19.43 $18.88 $7.696M 400.7K

Buyers (Bids)

No. Vol. Price($)
2 1100 $19.29
 

Sellers (Offers)

Price($) Vol. No.
$19.33 252 1
View Market Depth
Last trade - 16.10pm 13/06/2024 (20 minute delay) ?
Last
$19.35
  Change
0.490 ( 2.80 %)
Open High Low Volume
$19.14 $19.42 $18.88 94185
Last updated 15.59pm 13/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.